Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.J&J seeks US approval for leukemia drug
Tipifarnib, administered orally, is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML). As a drug intended to treat a
Tipifarnib, administered orally, is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML). As a drug intended to treat a
The company’s major shareholder, Charter Pacific Corporation Limited continued its support by participating in the placement and maintains its holding at 20.1%. Two of the company’s other major
As a premiere sponsor, Cialis will have a major interactive presence at the majority of BASS events, including the CITGO Bassmaster Tournament Trail, the Bassmaster Elite 50 Series
SCOLR Pharma also confirmed its intention to initiate bioequivalency testing of its extended release pseudoephedrine decongestant tablets to support an anticipated abbreviated new drug application (ANDA) expected to
The trial, named INDEX, was an open-label multi-center phase III trial that assessed the long-term safety and tolerability of Zomig (zolmitriptan) nasal spray 5mg in 538 adult patients
Researchers from Yale University School of Medicine used cancer cell lines established from patients who had failed to respond to standard anticancer drugs. In the laboratory, these cells
VP025 is being developed to target the chronic inflammation within the brain and central nervous system that is associated with a number of neurological diseases, including Alzheimer’s disease,
The trial will be conducted at both Merck and the HIV Vaccine Trials Network (HVTN) clinical trial sites in North and South America, the Caribbean, and Australia. The
This is the second project between the two companies; a study to research the genetics of myocardial infarction, or heart attack, was announced in January 2004. In this
The drug discovery and development collaboration between the two companies was initiated in November 1997 with the objective of developing new treatments targeting estrogen receptors (ERs). These may